Dosage Form Development Services

Dosage Form Development Services
Product Description

NerPharMa Srl. offers a wide range of services which includes dosage form development services. Features: it can support the development of sterile and oral solid dosage forms (conventional and nonconventional technologies), includes pre-formulation; formulation; process development; clinical supply; scale-up and technology transfer.

NerPharMa srl

  • Country/Region:
    Italy
  • On CPHI since:
    2015
  • Certificates:
    1
  • Employees:
    100 - 249
Company types
Contract Service
Manufacturer/Innovator
Primary activities
Pharmaceutical Company (generic finished products)

NerPharMa srl

  • Country/Region:
    Italy
  • On CPHI since:
    2015
  • Certificates:
    1
  • Employees:
    100 - 249
Company types
Contract Service
Manufacturer/Innovator
Primary activities
Pharmaceutical Company (generic finished products)

More Products from NerPharMa srl (2)

  • Analytical Services

    Product Analytical Services

    NerPharMa Srl. offers a wide range of services which includes analytical services. Features: the QC labs are fully equipped with all the instruments needed to covers such as method development and validation; accelerated stressing test; ICH stability studies; dissolution profiles; materials compatibility; ...
  • Clinical Supply Management

    Product Clinical Supply Management

    NerPharMa Srl. offers a wide range of services which includes clinical supply management. Features: it is authorised and has wide experience in the manufacturing, labelling, packaging and distribution of investigational medicinal products from laboratory to production scale for Phase 1 to Phase 4 clinical ...

NerPharMa srl resources (1)

  • Brochure A unique CDMO Partner

    NerPharMa is a CDMO with a strong expertise in Oncology, bringing highly potent compounds, new products and unique innovative technologies to the market delivering a wide range of GMP services. NerPharMa owns a wide and cutting-edge organizational structure able to ensure the API full development and production (in NerPharMa DS division) and finished products (in NerPharMa DP division) intended for the world market, as well as the research and development of innovative formulation and delivery systems, operating in accordance with cGMP and are authorized by the most relevant authorities: AIFA, FDA, ANVISA Brazil, China FDA, PMDA Japan and Russia.